Comments
Pharmaceutical company Ipca Laboratories Ltd has posted a robust growth in net income and net profit in the third quarter of the current year compared to the same quarter in the previous fiscal.
The company’s export income formed more than 50 per cent of its total income during the quarter.
The total income from operations during the third quarter was Rs 701.02 crore compared to Rs 614.83 crore in the same quarter in 2011-12. The net profit at Rs 87.89 crore was higher than Rs 63.93 crore during Q3 of 2011-12.
The company said that while income from domestic formulations was higher by 13 per cent at Rs 212.73 crore, export income was up by 16 per cent at Rs 442.37 crore. The EBITDA margin was 22.59 per cent and the net profit was higher by 37 per cent. The EPS was Rs 6.97 (Rs 5.08).
The company's stock was trading at Rs 481.30 (face value Rs 2), down by Rs 5.30 on the NSE with a trading volume of 1.72 lakh shares.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.